Imatinib
| Use attributes for filter ! | |
| Drug class | Tyrosine kinase inhibitor |
|---|---|
| Other names | imatinib mesylate |
| USAN | |
| Formula | C29H31N7O |
| Elimination half-life | 18 h (imatinib); 40 h (active metabolite) |
| License data | EMA |
| INN | |
| DailyMed | |
| US | |
| FDA | |
| Metabolism | liver (mainly CYP3A4-mediated) |
| ATC code | WHO |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951044 |
About Imatinib
Imatinib, sold under the brand name Gleevec among others, is a medication used to treat cancer. Specifically, it is used for chronic myelogenous leukemia and acute lymphocytic leukemia that are Philadelphia . . .